Sonova Holding stock
Price history
+44.85% over the period1 year: from CHF 199.65 (November 17, 2025) to CHF 289.20 (November 16, 2026), +44.85%.
Show chart data
Closing prices adjusted for splits: the last close of each month.
| Date | Close |
|---|---|
| November 16, 2026 | CHF 289.20 |
| October 30, 2026 | CHF 283.80 |
| September 30, 2026 | CHF 251.60 |
| August 31, 2026 | CHF 232.20 |
| July 31, 2026 | CHF 220.00 |
| June 30, 2026 | CHF 192.10 |
| May 29, 2026 | CHF 207.60 |
| April 30, 2026 | CHF 171.20 |
| March 31, 2026 | CHF 179.00 |
| February 27, 2026 | CHF 201.90 |
| January 30, 2026 | CHF 211.50 |
| December 30, 2025 | CHF 207.10 |
| November 28, 2025 | CHF 200.10 |
| November 17, 2025 | CHF 199.65 |
At a glance
The company
Manufactures and sells hearing care solutions including hearing instruments, cochlear implants and connected lifestyle devices worldwide
Latest results
Quarter to September 30, 2025 · EPS CHF 3.16
TickerLandia's take on Sonova Holding
- Pricier than usual relative to earnings: P/E on the latest fiscal year 32 vs a median of 26 over its last 10 fiscal years.
- Priced in line with similar companies: trailing 12-month P/E 32 vs 31 (+2%) in a group of 10.
- Strong point: Market momentum (90/100 in its group). Weak point: Growth (17/100).
Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks
Where the price stands
+0.84% from the 52-week high
Analysts · 19 analysts
Average targetCHF 253.26−12.30% vs. price
Buy 8 · Hold 8 · Sell 3 · Hold
TickerLandia Fingerprint: Sonova Holding
Compared with similar companies: very strong momentum and very low growth.
Financials and price compared with 31 companies in the medical devices industry, worldwide. Momentum and risk compared with 1,160 European stocks.
Pricehigh61
How much it costs relative to what it produces.
Metric Value Position in group EV/EBITDA 18.0 65 P/E (trailing 12 months) 31.7 57 Price/book 4.72 56 Forward P/E 23.8 68 Price/sales 3.42 56 Profitabilityhigh73
How much it earns on revenue and capital.
Metric Value Position in group Gross margin 73.7% 89 Operating margin 19.5% 69 Net margin 11.9% 63 ROE 20.5% 79 ROA 7.6% 66 Earnings stabilityhigh66
How steady its margins were over the last five annual reports.
Metric Value Position in group Margin variabilitycounts in reverse: lower means more earnings stability 1.5% 76 Loss-making yearscounts in reverse: lower means more earnings stability 0 of 5 annual reports 56 Growthvery low17
How fast revenue and earnings are growing.
Metric Value Position in group Average revenue growth (3 years) −1.20% 8 Revenue growth (year over year) −0.97% 5 Earnings growth (year over year) −8.37% 37 Financial strengthlow38
How well it would weather a hard period: debt, liquidity, interest.
Metric Value Position in group Net debt/EBITDAcounts in reverse: lower means more financial strength 1.18 43 Interest coverage 24.6 55 Debt/equitycounts in reverse: lower means more financial strength 0.61 40 Current ratio 1.24 15 Dividendaverage45
How much it returns to shareholders, and for how long.
Metric Value Position in group Consecutive dividend years 6 years 32 Dividend yield 1.6% 45 Payout ratio 56.7% 57 Market momentumvery strong90
How the stock has moved compared with the market.
Metric Value Position in group Relative strength (3 months) +15.04% 89 Relative strength (6 months) +43.46% 97 Distance from 200-day average +32.16% 97 1-year return +31.16% 76 Riskaverage44
How much the price swings.
Metric Value Position in group Volatility (60 days) 21.1% 24 Beta (1 year) 0.82 57 Maximum drawdown (12 months) 24.4% 51
Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 16, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated
Valuation
Sonova Holding is pricier than in the past and in line with similar companies
On the latest fiscal year's earnings (2026), Sonova Holding's P/E today is 32.1, above the median of its last 10 fiscal years (25.9; between 19.9 and 37.4 from 2017 to 2026). Sonova Holding's P/E (trailing 12 months): 31.7, in line with the median of a group of 10 similar companies (31.1).
Compared with 10 similar companies
| Metric | Sonova Holding | Position in the group | Band |
|---|---|---|---|
| P/E (trailing 12 months) | 31.7 | Middle | |
| Forward P/E | 23.7 | Middle | |
| Operating margin | 19.5% | High | |
| ROE | 20.5% | High | |
| Debt/equity | 0.61 | Middle |
P/E at fiscal year end; today on the latest fiscal year's earnings. Grey band: the middle half of the group; tick: the median; dot: Sonova Holding. All multiples and dividends
TickerLandia analysisHow it is calculated
The financials
Numbers and valuation
Full valuation- Market cap
- CHF 16.97B
- P/E
- 31.7
- EPS
- CHF 8.29
- Volume
- 132.07K
- Daily trading
- €50.43M
- Dividend yield
- 1.63%
- Last ex-dividend on June 19, 2026
How Sonova Holding is changing
All resultsRevenue grew 6.7% a year on average over the last 5 years
Operating margin fell from 21.0% to 19.5%
Profits turn into cash: free cash flow equal to 127% of net income
Returns
Sonova Holding returns with dividends
CHF 1,000 invested in Sonova Holding 5 years ago, on November 16, 2021, would be worth CHF 858 today with dividends reinvested: −14.18% in total, −3.01% per year. On price alone it would be CHF 783 (−21.67%).
| Period | Sonova Holding | SMI | CHF 1,000 becomes |
|---|---|---|---|
| 1 month | +4.03% | +5.87% | CHF 1,040 |
| 6 months | +61.25% | +15.25% | CHF 1,613 |
| Year to date | +39.64% | +14.84% | CHF 1,396 |
| 1 year | +48.38% | +20.94% | CHF 1,484 |
| 3 years | +33.06% | +43.15% | CHF 1,331 |
| 5 years | −14.18% | +21.33% | CHF 858 |
| 10 years | +165.40% | +92.52% | CHF 2,654 |
Over the last 6 months it has done better than 80% of the stocks in the Healthcare sector.
From 1 year up with dividends reinvested, before taxes; under a year price only. SMI: price only. Calculate your investment
The chart in detail
Sonova Holding: technical analysis
Sonova Holding is in an uptrend: the price is above its 50- and 200-session moving averages, and the 200-session average is rising. The price is 27.6% below its all-time closing high (CHF 398.80, November 4, 2021).
- Trend
- Upward
- RSI (14 sessions)
- 63
- Between 30 and 70
- vs 200-session average
- +33.11%
Active signals
The price is moving in an unusually narrow range compared with the last year.
since November 10, 2026
Support and resistance
Price areas where Sonova Holding has stopped several times in the last year. They describe the chart; they are not forecasts.
- No resistance above: the price is near the highs of the year
- Last priceCHF 288.80
- SupportCHF 225.37−21.96%3 touches, last on September 15, 2026
- SupportCHF 210.82−27.00%5 touches, last on July 7, 2026
- SupportCHF 204.10−29.33%3 touches, last on March 10, 2026
Volatility and risk
Over the last year it has moved less than the SMI.
- Beta (1 year) vs SMI
- 0.78
- Volatility (60 sessions, annualised)
- 21.1%
- Largest fall in the last year
- −24.44%
Close of November 16, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it
Sonova Holding: seasonality
Average monthly price change over 32 years
Over the last 32 years, the strongest month for Sonova Holding has been November: +5.19% on average, positive in 19 years out of 31. The weakest has been June: −0.32% on average, positive in 13 years out of 32.
Show chart data
| Month | Average | Median | Positive years |
|---|---|---|---|
| January | +0.35% | +0.90% | 17 of 32 |
| February | +3.05% | +0.82% | 19 of 32 |
| March | +0.74% | +1.19% | 17 of 32 |
| April | +2.80% | +2.82% | 18 of 32 |
| May | +4.10% | +4.50% | 22 of 32 |
| June | −0.32% | −0.47% | 13 of 32 |
| July | +1.48% | +1.90% | 21 of 32 |
| August | −0.21% | +1.59% | 19 of 32 |
| September | +0.61% | +1.19% | 19 of 32 |
| October | +0.48% | +0.65% | 17 of 32 |
| November | +5.19% | +2.24% | 19 of 31 |
| December | +0.43% | 0.00% | 15 of 31 |
Price change only, dividends excluded. Past seasonality does not predict future moves.
The company
Sonova Holding and its competitors
Sales reach customers in Switzerland, the United States, the rest of the Americas, Europe, the Middle East, Africa and Asia Pacific. The group designs and manufactures hearing instruments sold under the Phonak, Unitron, Hansaton and Sennheiser names, and runs audiological care under local banners such as Boots Hearingcare, Connect Hearing and Geers. Its Advanced Bionics brand covers cochlear implants, while a Lifestyle-Aligned unit develops connected products that integrate AI and digital features.
- Headquarters
- Stäfa, Switzerland
- Employees
- 18,570
- Founded
- 1947
- Chief executive
- Eric Bernard
| Company | Market cap | Operating margin | P/E (trailing 12 months) | 6 months |
|---|---|---|---|---|
| Sonova HoldingSOON | $20.24B | 19.5% | 31.7 | +61.25% |
| Koninklijke PhilipsPHIA | $29.64B | 8.8% | 66.9 | +26.10% |
| Smith & NephewSN. | $13.03B | 14.2% | 21.4 | +5.76% |
| DemantDEMANT | $10.92B | 17.2% | 30.5 | +48.01% |
| GetingeGETI.B | $7.63B | 14.3% | 27.1 | +49.29% |
| Siemens HealthineersSHL | $54.36B | 13.5% | 22.3 | +31.74% |
Same industry or related industries, similar size. Compare Sonova Holding with its competitors · Full profile
